Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Experimental Cell Research|June 1, 2007
Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomesKousuke Kasahara, Yuji Nakayama, Akio Kihara, et al.
Archives of Biochemistry and Biophysics|August 19, 2007
Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cellsTakahisa Kuga, Yuji Nakayama, Masaki Hoshino, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 18, 2006
[Late-onset urethrorectal fistula after laparoscopic radical prostatectomy: report of a case]Satoru Minamida, Masatsugu Iwamura, Mayumi Tsuchida, et al.
Vascular|May 22, 2016
Prognostic factor of the two-year mortality after revascularization in patients with critical limb ischemiaKoichi Morisaki, Takuya Matsumoto, Yutaka Matsubara, et al.
Vascular|July 31, 2015
Elective endovascular vs. open repair for abdominal aortic aneurysm in octogenariansKoichi Morisaki, Takuya Matsumoto, Yutaka Matsubara, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 31, 2015
Late type III endoleak of a Powerlink stent graft: report of a caseKoichi Morisaki, Takuya Matsumoto, Yutaka Matsubara, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2011
Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemiaTaichi Ohshiro, Daisuke Matsuda, Kent Sakai, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, et al.
Pageof 12